Carisma Therapeutics (CARM) Revenue & Revenue Breakdown
Carisma Therapeutics Revenue Highlights
0
Latest Revenue (Q)
$3.73M
Main Segment (Y)
Milestones
Carisma Therapeutics Revenue by Period
Carisma Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $14.92M | 51.71% |
| 2022-12-31 | $9.83M | -62.95% |
| 2021-12-31 | $26.54M | 136.24% |
| 2020-12-31 | $11.24M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2017-12-31 | $425.00K | -98.58% |
| 2016-12-31 | $29.98M | 2928.38% |
| 2015-12-31 | $990.00K | -55.86% |
| 2014-12-31 | $2.24M | 68.14% |
| 2013-12-31 | $1.33M | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | - |
Carisma Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Carisma Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $3.73M | 2.08% |
| 2024-12-31 | $3.65M | 7.92% |
| 2024-09-30 | $3.38M | -63.19% |
| 2024-06-30 | $9.20M | 170.74% |
| 2024-03-31 | $3.40M | -20.80% |
| 2023-12-31 | $4.29M | 12.07% |
| 2023-09-30 | $3.83M | 7.50% |
| 2023-06-30 | $3.56M | 9.77% |
| 2023-03-31 | $3.24M | -13.08% |
| 2022-12-31 | $3.73M | 44.72% |
| 2022-09-30 | $2.58M | -4.62% |
| 2022-06-30 | $2.70M | 228.83% |
| 2022-03-31 | $822.00K | -95.89% |
| 2021-12-31 | $20.00M | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $2.23M | -48.17% |
| 2021-03-31 | $4.31M | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2020-09-30 | $11.24M | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | -100.00% |
| 2017-03-31 | $425.00K | -48.48% |
| 2016-12-31 | $825.00K | -97.12% |
| 2016-09-30 | $28.65M | 10242.96% |
| 2016-06-30 | $277.00K | 20.96% |
| 2016-03-31 | $229.00K | -59.47% |
| 2015-12-31 | $565.00K | 743.28% |
| 2015-09-30 | $67.00K | -41.23% |
| 2015-06-30 | $114.00K | -53.28% |
| 2015-03-31 | $244.00K | -34.93% |
| 2014-12-31 | $375.00K | -30.43% |
| 2014-09-30 | $539.00K | -29.17% |
| 2014-06-30 | $761.00K | 33.98% |
| 2014-03-31 | $568.00K | 11.37% |
| 2013-12-31 | $510.00K | -18.01% |
| 2013-09-30 | $622.00K | 207.92% |
| 2013-06-30 | $202.00K | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | - |
Carisma Therapeutics generated $3.73M in revenue during Q1 2025, up 2.08% compared to the previous quarter, and up 86.94% compared to the same period a year ago.
Carisma Therapeutics Revenue Breakdown
Carisma Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 20 |
|---|---|---|
| Milestones | $2.00M | - |
| License Revenue | - | $11.24M |
Latest
Carisma Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Milestones (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 25 | Dec 24 | Sep 24 |
|---|---|---|---|
| Reporting Segment | $3.73M | - | - |
| Milestones | - | - | $2.00M |
Latest
Carisma Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Reporting Segment (100.00%).
Carisma Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CDT | CDT Equity | $2.46B | $698.22M |
| SPRC | SciSparc | $2.88M | $907.00K |
| ONCO | Onconetix | $58.47K | $406.86K |
| CARM | Carisma Therapeutics | - | $3.73M |
| ASBP | Aspire Biopharma | - | - |
| INDP | Indaptus Therapeutics | - | - |
| REVB | Revelation Biosciences | - | - |
| ENVB | Enveric Biosciences | - | - |
| JSPR | Jasper Therapeutics | - | - |
| SLRX | Salarius Pharmaceuticals | - | - |
| SLXN | Silexion Therapeutics | - | - |